JUDKOWITZ HARVEY 4
4 · Algorhythm Holdings, Inc. · Filed Mar 31, 2026
Research Summary
AI-generated summary of this filing
Algorhythm (RIME) Director Harvey Judkowitz Receives Awards
What Happened Harvey Judkowitz, a director of Algorhythm Holdings, Inc. (RIME), was granted two awards on 2025-11-20: a restricted stock award (RSA) for 19,532 shares and a non‑qualified stock option to purchase 19,532 shares. Both transactions are reported with an acquisition price of $0.00 (reported value $0), indicating these were compensation grants under the company's equity plan rather than open‑market purchases or sales.
Key Details
- Transaction date: 2025-11-20; Form 4 filed: 2026-03-31 (appears to be a late filing vs. the 2-business-day rule).
- RSA: 19,532 restricted shares granted (reported as acquired at $0.00).
- Option: Non‑qualified option to purchase 19,532 shares (reported as acquired at $0.00; recorded as a derivative).
- Vesting: Both the RSA and the option vest in equal quarterly installments over one year from grant (per footnotes).
- Plan: Grants made under the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan.
- Shares owned after transaction: not disclosed in the provided excerpt.
Context These awards are standard equity compensation: the RSA is a contingent right to shares that vest over time, and the option gives the right to buy shares as it vests (not an immediate exercise). Because no sale or open‑market purchase occurred, this filing does not indicate an immediate cash investment or liquidation by the insider. The late filing may affect timely disclosure for investors tracking insider activity.
Insider Transaction Report
- Award
Common Stock
[F1]2025-11-20+19,532→ 19,532 total - Award
Stock Option (right to buy)
[F2][F3]2025-11-20+19,532→ 19,532 totalExercise: $1.28Exp: 2035-11-20→ Common Stock (19,532 underlying)
Footnotes (3)
- [F1]The reported transaction involved the Reporting Person's receipt of a restricted stock award for 19,532 shares of the Issuer's common stock (the "RSA"). The RSA was granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan. The RSA represents a contingent right to receive 19,532 shares of the Issuer's common stock. The RSA vests in equal quarterly installments over a period of one year from the date of grant.
- [F2]The reported transaction involved the Reporting Person's receipt of a non-qualified stock option to purchase 19,532 shares of the Issuer's common stock. The option was granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan.
- [F3]The shares subject to the non-qualified stock option vest and become exercisable in equal quarterly installments over a period of one (1) year from the date of grant.